Stryker Shares Outstanding 2010-2025 | SYK

Stryker shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Stryker shares outstanding for the quarter ending March 31, 2025 were 0.386B, a 0.34% increase year-over-year.
  • Stryker 2024 shares outstanding were 0.386B, a 0.5% increase from 2023.
  • Stryker 2023 shares outstanding were 0.384B, a 0.39% increase from 2022.
  • Stryker 2022 shares outstanding were 0.382B, a 0.03% decline from 2021.
Stryker Annual Shares Outstanding
(Millions of Shares)
2024 386
2023 384
2022 382
2021 382
2020 380
2019 380
2018 380
2017 380
2016 379
2015 381
2014 383
2013 382
2012 383
2011 390
2010 400
2009 399
Stryker Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 386
2024-12-31 386
2024-09-30 386
2024-06-30 385
2024-03-31 385
2023-12-31 384
2023-09-30 384
2023-06-30 384
2023-03-31 383
2022-12-31 382
2022-09-30 382
2022-06-30 382
2022-03-31 383
2021-12-31 382
2021-09-30 383
2021-06-30 382
2021-03-31 382
2020-12-31 380
2020-09-30 380
2020-06-30 376
2020-03-31 380
2019-12-31 380
2019-09-30 380
2019-06-30 380
2019-03-31 379
2018-12-31 380
2018-09-30 380
2018-06-30 380
2018-03-31 381
2017-12-31 380
2017-09-30 380
2017-06-30 380
2017-03-31 379
2016-12-31 379
2016-09-30 379
2016-06-30 379
2016-03-31 377
2015-12-31 381
2015-09-30 381
2015-06-30 381
2015-03-31 384
2014-12-31 383
2014-09-30 383
2014-06-30 383
2014-03-31 383
2013-12-31 382
2013-09-30 382
2013-06-30 381
2013-03-31 383
2012-12-31 383
2012-09-30 383
2012-06-30 383
2012-03-31 384
2011-12-31 390
2011-09-30 388
2011-06-30 392
2011-03-31 394
2010-12-31 400
2010-09-30 398
2010-06-30 399
2010-03-31 400
2009-12-31 399
2009-09-30 400
2009-06-30 399
2009-03-31 399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $152.832B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $223.656B 26.24
EssilorLuxottica (ESLOY) France $137.378B 0.00
Medtronic (MDT) Ireland $117.532B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.462B 0.00
Haleon (HLN) United Kingdom $43.306B 24.72
ResMed (RMD) United States $40.680B 30.56
Agilent Technologies (A) United States $33.534B 21.86
GE HealthCare Technologies (GEHC) United States $32.803B 15.37
Koninklijke Philips (PHG) Netherlands $25.816B 17.08
Terumo (TRUMY) Japan $25.125B 32.63
Insulet (PODD) United States $20.991B 82.39
Zimmer Biomet Holdings (ZBH) United States $18.463B 11.86
Baxter (BAX) United States $14.395B 10.75
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.805B 23.68
Lantheus Holdings (LNTH) United States $4.970B 12.54
Perrigo (PRGO) Ireland $3.781B 9.58
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.644B 16.60
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.383B 28.11
ICU Medical (ICUI) United States $3.088B 22.77
LeMaitre Vascular (LMAT) United States $1.852B 41.40
AtriCure (ATRC) United States $1.739B 0.00
QuidelOrtho (QDEL) United States $1.643B 11.30
Acuren (TIC) United States $1.391B 0.00
Green Thumb Industries (GTBIF) United States $1.271B 28.60
AdaptHealth (AHCO) United States $1.232B 12.51
Phibro Animal Health (PAHC) United States $1.132B 14.47
Neogen (NEOG) United States $1.019B 16.19
Curaleaf Holdings (CURLF) Canada $0.939B 0.00
InMode (INMD) Israel $0.879B 8.13
Kestra Medical Technologies (KMTS) United States $0.856B 0.00
Valneva SE (VALN) France $0.651B 0.00
Tilray Brands (TLRY) Canada $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.614B 0.00
Evolus (EOLS) United States $0.578B 0.00
Owens & Minor (OMI) United States $0.549B 4.56
CeriBell (CBLL) United States $0.539B 0.00
Surmodics (SRDX) United States $0.535B 0.00
ZimVie (ZIMV) United States $0.526B 20.52
SNDL (SNDL) Canada $0.378B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.342B 0.00
Cresco Labs (CRLBF) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.308B 0.00
VAREX IMAGING (VREX) United States $0.307B 11.29
Quanterix (QTRX) United States $0.304B 0.00
Aurora Cannabis (ACB) Canada $0.254B 75.33
Cerus (CERS) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.244B 20.60
OraSure Technologies (OSUR) United States $0.239B 0.00
Omeros (OMER) United States $0.238B 0.00
Sanara MedTech (SMTI) United States $0.223B 0.00
Canopy Growth (CGC) Canada $0.215B 0.00
Verano Holdings (VRNOF) United States $0.215B 0.00
Exagen (XGN) United States $0.190B 0.00
Organigram Global (OGI) Canada $0.184B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.07
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.172B 0.00
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
TerrAscend (TSNDF) Canada $0.131B 0.00
FitLife Brands (FTLF) United States $0.117B 14.37
Jushi Holdings (JUSHF) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.62
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
United-Guardian (UG) United States $0.036B 12.51
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00